AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Priced: EUR404.8M Bain Capital Euro CLO 2025-2 new issue via Citi
ByAinvest
Wednesday, Jul 16, 2025 12:56 pm ET1min read
Priced: EUR404.8M Bain Capital Euro CLO 2025-2 new issue via Citi
Title: Bain Capital Euro CLO 2025-2 New Issue via CitiBain Capital has announced the issuance of a new Euro Collateralized Loan Obligation (CLO) with a total value of EUR404.8 million, scheduled to mature in 2025. The transaction, which includes a new issue of senior notes, is being facilitated by Citigroup.
The new issue, known as Bain Capital Euro CLO 2025-2, is part of Bain Capital's ongoing strategy to raise capital for its investment activities. The senior notes have a maturity date of July 2, 2025, and are priced at EUR404.8 million. This issuance is expected to provide investors with exposure to a diversified portfolio of leveraged loans and other credit instruments.
The transaction underscores Bain Capital's commitment to the European market and its ability to secure financing from leading financial institutions such as Citigroup. The CLO structure allows Bain Capital to manage its risk exposure while providing investors with a stable income stream and potential capital appreciation.
Key Details:
- Issuer: Bain Capital
- Instrument: Euro CLO 2025-2 Senior Notes
- Maturity Date: July 2, 2025
- Total Value: EUR404.8 million
- Price: EUR404.8 million
- Facilitator: Citigroup
Market Reaction:
The issuance of the Bain Capital Euro CLO 2025-2 has been well-received by market participants. Investors have shown interest in the diversified credit portfolio offered by the CLO, which includes exposure to various sectors and geographies. The strong performance of the European debt markets has also contributed to the positive reception of the new issue.
References:
[1] https://www.wienerborse.at/en/bonds/?c7928-page=28&c7928-sort=isin&cHash=0a8a4113fe0faf2fe7afccdf182bad67&per-page=50
[2] https://pe-insights.com/bain-capital-and-kohlberg-back-10bn-pci-pharma-in-latest-biopharma-bet/
[3] https://www.americanbanker.com/news/citi-beats-expectations-with-help-from-markets-and-wealth
[4] https://www.morningstar.com/news/business-wire/20250710899343/wire-3-continues-to-raise-financing-accelerating-florida-focused-growth
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet